Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,218
  • Shares Outstanding, K 29,653
  • Annual Sales, $ 0 K
  • Annual Income, $ -53,470 K
  • 60-Month Beta -0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.53
Trade IMRX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.51
  • Number of Estimates 5
  • High Estimate -0.47
  • Low Estimate -0.54
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -18.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3600 +2.21%
on 05/24/24
1.7783 -21.84%
on 05/06/24
-0.1100 (-7.33%)
since 04/24/24
3-Month
1.3600 +2.21%
on 05/24/24
7.6800 -81.90%
on 03/04/24
-5.0700 (-78.48%)
since 02/23/24
52-Week
1.3600 +2.21%
on 05/24/24
11.9200 -88.34%
on 06/21/23
-5.1100 (-78.62%)
since 05/24/23

Most Recent Stories

More News
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.0900 (+2.83%)
ONC.TO : 1.49 (+2.76%)
RHHBY : 31.6000 (-0.60%)
MRUS : 59.99 (+36.12%)
MGNX : 4.55 (-1.73%)
IMRX : 1.3900 (-2.11%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

ONCY : 1.0900 (+2.83%)
ONC.TO : 1.49 (+2.76%)
BLRX : 0.6850 (+13.24%)
IMRX : 1.3900 (-2.11%)
CADL : 7.80 (-27.03%)
Immuneering Corporation (IMRX) Reports Q1 Loss, Misses Revenue Estimates

Immuneering Corporation (IMRX) delivered earnings and revenue surprises of 5.56% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

IMRX : 1.3900 (-2.11%)
AADI : 1.8400 (+1.10%)
Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last?

Morphic Holding, Inc. (MORF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase...

MORF : 30.80 (+10.95%)
IMRX : 1.3900 (-2.11%)
Immuneering Corporation (IMRX) Surges 18.5%: Is This an Indication of Further Gains?

Immuneering Corporation (IMRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

IMRX : 1.3900 (-2.11%)
CELU : 3.46 (-0.29%)
Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 102.51%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 102.5% in Immuneering Corporation (IMRX). While the effectiveness of this highly sought-after metric is questionable,...

IMRX : 1.3900 (-2.11%)
Why Shares of Immuneering Jumped This Week

Immuneering is ready to share information regarding its lead therapy.

IMRX : 1.3900 (-2.11%)
Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock?

Immuneering Corporation (IMRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near...

IMRX : 1.3900 (-2.11%)
ARCT : 30.41 (-2.56%)
Does Immuneering Corporation (IMRX) Have the Potential to Rally 210.19% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 210.2% in Immuneering Corporation (IMRX). While the effectiveness of this highly sought-after metric is questionable,...

IMRX : 1.3900 (-2.11%)
Immuneering Corporation (IMRX) Reports Q4 Loss, Misses Revenue Estimates

Immuneering Corporation (IMRX) delivered earnings and revenue surprises of 13.79% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

IMRX : 1.3900 (-2.11%)
PSTX : 2.97 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 1.5300
2nd Resistance Point 1.4900
1st Resistance Point 1.4400
Last Price 1.3900
1st Support Level 1.3500
2nd Support Level 1.3100
3rd Support Level 1.2600

See More

52-Week High 11.9200
Fibonacci 61.8% 7.8861
Fibonacci 50% 6.6400
Fibonacci 38.2% 5.3939
Last Price 1.3900
52-Week Low 1.3600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar